Social cognition, facial expression recognition, Parkinson's, motor function
MSci Pharmacology - University of Manchester
Molly completed her MSci in Pharmacology at the University of Manchester in 2020. Her Master’s degree involved researching the effects of exercise on rat models of schizophrenia, with a focus on the cognitive deficits that occur in schizophrenia. She has an interest in studying cognitive symptoms in both neurodegenerative diseases and psychiatric disorders. Molly is now completing a PhD supported by the Midlands Integrative Biosciences Training Partnership (MIBTP), a BBSRC-funded doctoral training programme. Her PhD aims to develop a mechanistic understanding of the role that dopamine plays in social cognition. These results will have important implications for individuals with Parkinson’s Disease.
- 1 Similar Profiles